NCT03577847

Brief Summary

To counteract long term sequelae from stroke, ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation is required. In this study, the investigators are moving the essential first diagnosis and treatment out into the community close to where the patient live, thus shortening the all important time from debut of symptoms to thrombolytic treatment improving the prognosis of stroke patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 5, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2020

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

April 14, 2021

Status Verified

April 1, 2021

Enrollment Period

2.4 years

First QC Date

January 9, 2018

Last Update Submit

April 13, 2021

Conditions

Keywords

Stroke, Thrombolysis, Rural CT

Outcome Measures

Primary Outcomes (1)

  • Thrombolytic treatment

    The proportion of patients with ischaemic stroke receiving thrombolytic treatment in percent.

    3 months

Secondary Outcomes (4)

  • Ictus to needle time

    3 months

  • Functional status

    3 months

  • Cognitive status

    3 months

  • Depression

    3 months

Study Arms (2)

1

Intervention group: Stroke patients investigated with rural CT scanning at HSS, Ål. Patients living in the municipalities of Hol, Ål, Gol, Hemsedal and Nes.

Diagnostic Test: Rural CT scanning

2

Control-group: Stroke patients with similar transportation time to hospital, but no access to rural CT scanning. Patients living in the municipalities of Nore- and Uvdal, Vang, Øystre and Vestre Slidre, Lesja, Vågå, Lom, Dovre, Skjåk and Sel.

Interventions

Rural CT scanningDIAGNOSTIC_TEST

Rural computer tomography for acute stroke

Also known as: Thrombolysis
1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Intervention group (access to local CT): Patients from the municipalities Hol, Ål, Gol, Hemsedal and Nes. Control group (no local CT): Patients from the municipalities Nore and Uvdal, Vang, Øystre- and Vestre Slidre, Lesja, Skjåk, Lom, Dovre, Vågå and Sel.

You may qualify if:

  • Patients over 18 years being investigated by CT within 24 hours for acute symptoms of stroke.
  • Fullfilling criteria for the diagnosis acute stroke as described by the Norwegian stroke registry.
  • Giving informed consent.

You may not qualify if:

  • Symptoms not due to ischaemic or haemorrhagic stroke as adjudicated at discharge.
  • Not able to cooperate to 3 months follow up.
  • Not giving informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vestre Viken Hospital Trust

Hønefoss, Buskerud, 3004, Norway

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Jorgen M Ibsen, MD

    Vestre Viken Hospital Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2018

First Posted

July 5, 2018

Study Start

November 20, 2017

Primary Completion

April 7, 2020

Study Completion

December 31, 2021

Last Updated

April 14, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations